Cargando…
Long-Term Treatment with Gadopentetic Acid or Gadodiamide Increases TRPC5 Expression and Decreases Adriamycin Nuclear Accumulation in Breast Cancer Cells
Gadopentetic acid and gadodiamide are paramagnetic gadolinium-based contrast agents (GBCAs) that are routinely used for dynamic contrast-enhanced magnetic resonance imaging (MRI) to monitor disease progression in cancer patients. However, growing evidence indicates that repeated administration of GB...
Autores principales: | Zhang, Weiheng, Wang, Mengyuan, Lv, Weizhen, White, Fletcher A., Chen, Xingjuan, Obukhov, Alexander G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177392/ https://www.ncbi.nlm.nih.gov/pubmed/37174704 http://dx.doi.org/10.3390/cells12091304 |
Ejemplares similares
-
Gadolinium Retention and Clearance in the Diabetic Brain after Administrations of Gadodiamide, Gadopentetate Dimeglumine, and Gadoterate Meglumine in a Rat Model
por: Wang, Shu-ting, et al.
Publicado: (2019) -
Transient Receptor Potential Canonical (TRPC) Channels: Then and Now
por: Chen, Xingjuan, et al.
Publicado: (2020) -
The TRPC6 inhibitor, larixyl acetate, is effective in protecting against traumatic brain injury-induced systemic endothelial dysfunction
por: Chen, Xingjuan, et al.
Publicado: (2019) -
Long-term spironolactone treatment reduces coronary TRPC expression, vasoconstriction, and atherosclerosis in metabolic syndrome pigs
por: Li, Wennan, et al.
Publicado: (2017) -
PKC-dependent Phosphorylation of the H1 Histamine Receptor Modulates TRPC6 Activity
por: Chen, Xingjuan, et al.
Publicado: (2014)